SPONSOR

University of Virginia

Total Trials

Recruiting

Phases

EARLY_Phase 1, Phase 2, Phase 4, Phase 1, Phase 2, Phase 1, Phase 2, Phase 3

Conditions studied: Hyperandrogenism Polycystic Ovary Syndrome Puberty Lung Transplant Rejection Heart Failure Preserved Ejection Fraction Epicardial Adipose Tissue Brain Injury Brain Tumors Craniotomy Surgery Pain

University of Virginia is a clinical research sponsor with 15 registered studies on ClinicalTrials.gov, of which 15 are actively recruiting participants. Research covers conditions including Hyperandrogenism, Polycystic Ovary Syndrome, Puberty, Lung Transplant Rejection.

The trial portfolio spans EARLY_Phase 1, Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University of Virginia

How many clinical trials has University of Virginia sponsored?

ClinicalMetric currently tracks 15 clinical trials sponsored by University of Virginia, of which 15 are actively recruiting participants. These trials cover conditions including Hyperandrogenism, Polycystic Ovary Syndrome, Puberty. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does University of Virginia research focus on?

University of Virginia clinical trials span Hyperandrogenism, Polycystic Ovary Syndrome, Puberty, Lung Transplant Rejection, Heart Failure Preserved Ejection Fraction, and additional conditions. The research pipeline includes EARLY_Phase 1, Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a University of Virginia clinical trial?

To participate in a University of Virginia trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Virginia trials with current recruitment status updated daily.

University of Virginia

Frequently Asked Questions — University of Virginia

Clinical Trials by University of Virginia

Hyperandrogenemia and Altered Day-night LH Pulse Patterns

Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection

Epicardial Adipose Tissue Composition and Heart Failure With Preserved Ejection Fraction

Pain Control and Quality of Recovery After Intravenous Methadone Versus Intravenous Remifentanil in Craniotomy Surgery

Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?

Tuberculosis in Rural and Malnourished Populations

Study of EGFRBi Armed Fresh PBMC in Metastatic or Unresectable Pancreatic Cancer

Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant

Effect of Dapagliflozin on Microvascular Function in Women With Symptoms of Coronary Artery Disease

Mechanistic Clinical Trial of Advanced Imaging for CRT

weSIPsmarter: Evaluating a Digital Health Intervention Aimed at Reducing Sugary Drinks Among Rural Head Start Preschoolers and Their Parents

Evaluation of a Novel Insulin Sensitizer in People With Type 1 Diabetes

Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer

Effects of Exercise and GLP-1 Agonism on Muscle Microvascular Perfusion and Insulin Action in Adults With Metabolic Syndrome

Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS